If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Update on Harpin

30 Jul 2013 07:01

RNS Number : 4174K
Plant Health Care PLC
29 July 2013
 



 

 

 

30 July 2013

 

PLANT HEALTH CARE PLC

 

Update on Harpin

 

Plant Health Care (AIM: PHC) announced a new strategy in March 2013, based on accelerating the development of new generation Harpin products and ramping up sales of products based on the current Harpin αβ over the next three years.

 

As part of the implementation of that strategy, PHC announced today that the Company and Monsanto have mutually agreed to discontinue the 2008 Harpin αβ agreement which granted Monsanto certain exclusive rights to develop and sell Harpin αβ as a seed treatment. Under the terms of this mutual agreement, all licensed rights have reverted back to PHC and PHC has purchased Monsanto's remaining Harpin αβ inventory. This agreement enables PHC to continue to build on the growth in use of Harpin αβ by resuming direct control of the product for seed treatment and gaining the flexibility to partner with others to develop and sell into all crop markets on a global basis. 

 

The Company is currently exploring potential partnerships with a number of parties and anticipates reaching agreement with one or more of them by the end of this year. This will complement the recent agreement with Arysta Life Sciences to further drive the growth in use of Harpin αβ as a foliar application. As disclosed in March 2013, the Company continues to adopt a more cautious approach to budgeting for future revenues and notes that the precise timing of these agreements and revenues remains uncertain.

 

Following the spring seed treatment season, which was adversely impacted due to inclement weather across much of the corn/soybean belt of the US, and a recent in depth review of on-ground sales and inventories, the Company now believes that the process of exhaustion of existing inventory will continue into 2014.

 

Further details regarding product revenues by category will be provided at the time of the Interim Statement on September 16, 2013.

 

- ENDS-

 

 

About Plant Health Care, plc: Plant Health Care, plc ("PHC") is a leading provider of naturally derived products for plants and soil. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

For further information please contact:

 

Plant Health Care plc

 

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

Stephen Weaver, Finance Director

Tel: +1-412-826-5488

 

 

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

 

 

 

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden / Sophie Moate

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEUEEUFDSELW
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.